Brahmer J - Search Results

1

Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.

Lynch TJ Jr, Spigel DR, Brahmer J, Fischbach N, Garst J, Jahanzeb M, Kumar P, Vidaver RM, Wozniak AJ, Fish S, Flick ED, Leon L, Hazard SJ, Kosty MP; ARIES Study Investigators. Lynch TJ Jr, et al. Among authors: brahmer j. J Thorac Oncol. 2014 Sep;9(9):1332-9. doi: 10.1097/JTO.0000000000000257. J Thorac Oncol. 2014. PMID: 25122429 Free article. Clinical Trial.

2

Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.

Lin TL, Brahmer JR. Lin TL, et al. Curr Oncol Rep. 2004 Jul;6(4):251-8. doi: 10.1007/s11912-004-0032-3. Curr Oncol Rep. 2004. PMID: 15161575 Review.

3

Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.

Monnerat C, Le Chevalier T, Kelly K, Obasaju CK, Brahmer J, Novello S, Nakamura T, Liepa AM, Bozec L, Bunn PA Jr, Ettinger DS. Monnerat C, et al. Among authors: brahmer j. Clin Cancer Res. 2004 Aug 15;10(16):5439-46. doi: 10.1158/1078-0432.CCR-04-0218. Clin Cancer Res. 2004. PMID: 15328182 Clinical Trial.

4

Adjuvant therapy for resected non-small-cell lung cancer: past, present, and future.

Juergens RA, Brahmer JR. Juergens RA, et al. Curr Oncol Rep. 2005 Jul;7(4):248-54. doi: 10.1007/s11912-005-0046-5. Curr Oncol Rep. 2005. PMID: 15946582 Review.

5

Adjuvant treatment in non-small cell lung cancer: Where are we now?

Juergens RA, Brahmer JR. Juergens RA, et al. J Natl Compr Canc Netw. 2006 Jul;4(6):595-600. doi: 10.6004/jnccn.2006.0049. J Natl Compr Canc Netw. 2006. PMID: 16813727 Review.

6

Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.

Juergens R, Brahmer J, Ettinger D. Juergens R, et al. Among authors: brahmer j. Cancer Chemother Pharmacol. 2007 Apr;59(5):621-9. doi: 10.1007/s00280-006-0304-8. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937106 Clinical Trial.

7

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Sandler A, et al. Among authors: brahmer j. N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884. N Engl J Med. 2006. PMID: 17167137 Free article. Clinical Trial.

8

Second-line Therapy for advanced non-small-cell lung cancer.

Hann CL, Brahmer JR. Hann CL, et al. Curr Oncol Rep. 2006 Jul;8(4):243-7. doi: 10.1007/s11912-006-0027-3. Curr Oncol Rep. 2006. PMID: 17254522 Review.

9

Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.

Brahmer JR, Ettinger DS. Brahmer JR, et al. Respirology. 2007 May;12(3):320-5. doi: 10.1111/j.1440-1843.2007.01081.x. Respirology. 2007. PMID: 17539833 Review.

10

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

Taguchi F, Solomon B, Gregorc V, Roder H, Gray R, Kasahara K, Nishio M, Brahmer J, Spreafico A, Ludovini V, Massion PP, Dziadziuszko R, Schiller J, Grigorieva J, Tsypin M, Hunsucker SW, Caprioli R, Duncan MW, Hirsch FR, Bunn PA Jr, Carbone DP. Taguchi F, et al. Among authors: brahmer j. J Natl Cancer Inst. 2007 Jun 6;99(11):838-46. doi: 10.1093/jnci/djk195. J Natl Cancer Inst. 2007. PMID: 17551144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters